Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_assertion type Assertion NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_head.
- NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_assertion description "[The present data shows that Maitake D-Fraction suppresses the breast tumoral phenotype through a putative molecular mechanism modifying the expression of certain genes (such as IGFBP-7, ITGA2, ICAM3, SOD2, CAV-1, Cul-3, NRF2, Cycline E, ST7, and SPARC) that are involved in apoptosis stimulation, inhibition of cell growth and proliferation, cell cycle arrest, blocking migration and metastasis of tumoral cells, and inducing multidrug sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_provenance.
- NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_assertion evidence source_evidence_literature NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_provenance.
- NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_assertion SIO_000772 23875900 NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_provenance.
- NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_assertion wasDerivedFrom befree-20150227 NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_provenance.
- NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_assertion wasGeneratedBy ECO_0000203 NP709650.RAfx9Mpqh5ylrE3H9-_4xeTSESJAcnbl4xsS3Wm1EjrX4130_provenance.